Prevention of tumor metastasis formation by anti-variant CD44

doi:10.1084/jem.177.2.443

This Article

	Full Text (PDF, 1595K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Seiter, S.
	Articles by Zoller, M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Seiter, S.
	Articles by Zoller, M.


Social Bookmarking

	What's this?

ARTICLES

Prevention of tumor metastasis formation by anti-variant CD44

S Seiter, R Arch, S Reber, D Komitowski, M Hofmann, H Ponta, P Herrlich, S Matzku and M Zoller
Deutsches Krebsforschungszentrum, Institut fur Radiologie und Pathophysiologie, Heidelberg, Germany.

A splice variant of CD44 (CD44v) originally discovered on metastases of a rat pancreatic adenocarcinoma (BSp73ASML) has been shown by transfection to confer metastatic behavior to nonmetastatic tumor cells (Gunthert U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. Cell. 65:13). A monoclonal antibody (mAb), 1.1ASML, to the metastasis-specific domain of the CD44v molecule retards growth of lymph node and lung metastases of the metastatic tumor line BSp73ASML, and can efficiently prevent formation of metastases by the transfected line. The antibody is only effective when given before lymph node colonization. Anti-CD44v does not downregulate the expression of CD44v, and prevention of metastatic growth by anti-CD44v is not due to activation of any kind of immune defense. We suggest that the mAb interferes with proliferation of metastasizing tumor cells in the draining lymph node, most probably by blocking a ligand interaction. The interference with metastatic spread will greatly facilitate the exploration of the function of CD44v and, in particular, may also open new strategies for the therapy of human metastases.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Wallach-Dayan, S. B., Rubinstein, A. M., Hand, C., Breuer, R., Naor, D. (2008). DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis. Molecular Cancer Therapeutics 7: 1615-1623 [Abstract] [Full Text]
Ouhtit, A., Abd Elmageed, Z. Y., Abdraboh, M. E., Lioe, T. F., Raj, M. H.G. (2007). In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver. Am. J. Pathol. 171: 2033-2039 [Abstract] [Full Text]
Orian-Rousseau, V., Morrison, H., Matzke, A., Kastilan, T., Pace, G., Herrlich, P., Ponta, H. (2007). Hepatocyte Growth Factor-induced Ras Activation Requires ERM Proteins Linked to Both CD44v6 and F-Actin. Mol. Biol. Cell 18: 76-83 [Abstract] [Full Text]
Singh, R., Subramanian, S., Rhodes, J. M., Campbell, B. J. (2006). Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes. Glycobiology 16: 594-601 [Abstract] [Full Text]
Kim, M.-S., Park, M.-J., Moon, E.-J., Kim, S.-J., Lee, C.-H., Yoo, H., Shin, S.-H., Song, E.-S., Lee, S.-H. (2005). Hyaluronic Acid Induces Osteopontin via the Phosphatidylinositol 3-Kinase/Akt Pathway to Enhance the Motility of Human Glioma Cells. Cancer Res. 65: 686-691 [Abstract] [Full Text]
Schneider, S., Yochim, J., Brabender, J., Uchida, K., Danenberg, K. D., Metzger, R., Schneider, P. M., Salonga, D., Holscher, A. H., Danenberg, P. V. (2004). Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer. Clin. Cancer Res. 10: 1588-1596 [Abstract] [Full Text]
Zhang, G., He, B., Weber, G. F. (2003). Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer. Mol. Cell. Biol. 23: 6507-6519 [Abstract] [Full Text]
Antony, V.B. (2003). Immunological mechanisms in pleural disease. Eur Respir J 21: 539-544 [Abstract] [Full Text]
Xu, Y., Yu, Q. (2003). E-cadherin Negatively Regulates CD44-Hyaluronan Interaction and CD44-mediated Tumor Invasion and Branching Morphogenesis. J. Biol. Chem. 278: 8661-8668 [Abstract] [Full Text]
Dohadwala, M., Batra, R. K., Luo, J., Lin, Y., Krysan, K., Pold, M., Sharma, S., Dubinett, S. M. (2002). Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion. J. Biol. Chem. 277: 50828-50833 [Abstract] [Full Text]
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., Ponta, H. (2002). CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16: 3074-3086 [Abstract] [Full Text]
Weber, G. F., Bronson, R. T., Ilagan, J., Cantor, H., Schmits, R., Mak, T. W. (2002). Absence of the CD44 Gene Prevents Sarcoma Metastasis. Cancer Res. 62: 2281-2286 [Abstract] [Full Text]
Christ, O., Gunthert, U., Schmidt, D.-S., Zoller, M. (2002). Allogeneic reconstitution after nonmyeloablative conditioning: mitigation of graft-versus-host and host-versus-graft reactivity by anti-CD44v6. J. Leukoc. Biol. 71: 33-46 [Abstract] [Full Text]
Medico, E., Gentile, A., Celso, C. L., Williams, T. A., Gambarotta, G., Trusolino, L., Comoglio, P. M. (2001). Osteopontin Is an Autocrine Mediator of Hepatocyte Growth Factor-induced Invasive Growth. Cancer Res. 61: 5861-5868 [Abstract] [Full Text]
Asosingh, K., Günthert, U., De Raeve, H., Van Riet, I., Van Camp, B., Vanderkerken, K. (2001). A Unique Pathway in the Homing of Murine Multiple Myeloma Cells: CD44v10 Mediates Binding to Bone Marrow Endothelium. Cancer Res. 61: 2862-2865 [Abstract] [Full Text]
Wibulswas, A., Croft, D., Bacarese-Hamilton, I., McIntyre, P., Genot, E., Kramer, I. M. (2000). The CD44v7/8 Epitope as a Target to Restrain Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Am. J. Pathol. 157: 2037-2044 [Abstract] [Full Text]
Kanke, M., Fujii, M., Kameyama, K., Kanzaki, J., Tokumaru, Y., Imanishi, Y., Tomita, T., Matsumura, Y. (2000). Role of CD44 Variant Exon 6 in Invasion of Head and Neck Squamous Cell Carcinoma. Arch Otolaryngol Head Neck Surg 126: 1217-1223 [Abstract] [Full Text]
Stroomer, J. W. G., Roos, J. C., Sproll, M., Quak, J. J., Heider, K.-H., Wilhelm, B. J., Castelijns, J. A., Meyer, R., Kwakkelstein, M. O., Snow, G. B., Adolf, G. R., van Dongen, G. A. M. S. (2000). Safety and Biodistribution of 99mTechnetium-labeled Anti-CD44v6 Monoclonal Antibody BIWA 1 in Head and Neck Cancer Patients. Clin. Cancer Res. 6: 3046-3055 [Abstract] [Full Text]
Lin, Y.-H., Huang, C.-J., Chao, J.-R., Chen, S.-T., Lee, S.-F., Yen, J. J.-Y., Yang-Yen, H.-F. (2000). Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor. Mol. Cell. Biol. 20: 2734-2742 [Abstract] [Full Text]
Yu, Q., Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176 [Abstract] [Full Text]
Hebbard, L, Steffen, A, Zawadzki, V, Fieber, C, Howells, N, Moll, J, Ponta, H, Hofmann, M, Sleeman, J (2000). CD44 expression and regulation during mammary gland development and function. J. Cell Sci. 113: 2619-2630 [Abstract]
Protin, U., Schweighoffer, T., Jochum, W., Hilberg, F. (1999). CD44-Deficient Mice Develop Normally with Changes in Subpopulations and Recirculation of Lymphocyte Subsets. J. Immunol. 163: 4917-4923 [Abstract] [Full Text]
Toma, V., Hauri, D., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Gasser, T. C., Sauter, G., Roth, J. (1999). Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma. Am. J. Pathol. 155: 1427-1432 [Abstract] [Full Text]
Murray, P., Frampton, G, Nelson, P. (1999). Cell adhesion molecules. BMJ 319: 332-334 [Full Text]
Yu, Q., Stamenkovic, I. (1999). Localization of matrix metalloproteinase 9�to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13: 35-48 [Abstract] [Full Text]
Goodison, S., Yoshida, K., Churchman, M., Tarin, D. (1998). Multiple Intron Retention Occurs in Tumor Cell CD44 mRNA Processing. Am. J. Pathol. 153: 1221-1228 [Abstract] [Full Text]
Yakushijin, Y., Steckel, J., Kharbanda, S., Hasserjian, R., Neuberg, D., Jiang, W.-m., Anderson, I., Shipp, M. A. (1998). A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma. Blood 91: 4282-4291 [Abstract] [Full Text]
Sherman, L., Wainwright, D., Ponta, H., Herrlich, P. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb�outgrowth. Genes Dev. 12: 1058-1071 [Abstract] [Full Text]
Sleeman, J. P., Kondo, K., Moll, J., Ponta, H., Herrlich, P. (1997). Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44. J. Biol. Chem. 272: 31837-31844 [Abstract] [Full Text]
Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Kohler, G., Schopf, E., Ponta, H., Herrlich, P., Simon, J. C. (1997). An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function. JCB 137: 1137-1147 [Abstract] [Full Text]
Gakunga, P, Frost, G, Shuster, S, Cunha, G, Formby, B, Stern, R (1997). Hyaluronan is a prerequisite for ductal branching morphogenesis. Development 124: 3987-3997 [Abstract]
Bertolami, C. N., Messadi, D. V. (1994). The Role of Proteoglycans in Hard and Soft Tissue Repair. CROBM 5: 311-337 [Abstract] [Full Text]
Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G. J., Sharma, S., Huang, M., Pold, M., Batra, R. K., Dubinett, S. M. (2001). Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44. J. Biol. Chem. 276: 20809-20812 [Abstract] [Full Text]